Radiation Protection
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
137
NCT02692742
Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced Neutropenia
Phase: Phase 2
Role: Lead Sponsor
Start: Mar 31, 2016
Completion: Nov 30, 2017
Loading map...